Dasatinib Inhibits FLT3/ITD and PTPN11mutated Acute Myeloid Leukemia Cells Overexpressing SRC Tyrosine Kinases

被引：0
|
作者：
Tavor, Sigal [1 ]
Shalit, Tali [2 ]
Ilani, Noa Chapal [3 ]
Moskovitz, Yoni [3 ]
Livnat, Nir [2 ]
Groner, Yoram [2 ]
Bar, Haim [2 ]
Plotnikov, Alexander [2 ]
Kaushansky, Nathali [3 ]
Shlush, Liran I. [3 ]
机构：
[1] Assuta Med Ctr, Hematooncol, Tel Aviv, Israel
[2] Weizmann Inst Sci, Rehovot, Israel
[3] Weizmann Inst Sci, Dept Immunol, Rehovot, Israel
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-128016
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1451
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Dasatinib response in acute myeloid leukemia is correlated with FLT3/ITD, PTPN11 mutations and a unique gene expression signature
    Tavor, Sigal
    Shalit, Tali
    Ilani, Noa Chapal
    Moskovtiz, Yoni
    Livnat, Nir
    Groner, Yoram
    Barr, Haim
    Minden, Mark D.
    Plotnikov, Alexander
    Deininger, Michael W.
    Kaushansky, Nathali
    Shlush, Liran I.
    HAEMATOLOGICA, 2020, 105 (12) : 2795 - 2804
  • [2] Pim kinases modulate resistance to FLT3 tyrosine kinase inhibitors in FLT3-ITD acute myeloid leukemia
    Green, Alexa S.
    Maciel, Thiago T.
    Hospital, Marie-Anne
    Yin, Chae
    Mazed, Fetta
    Townsend, Elizabeth C.
    Pilorge, Sylvain
    Lambert, Mireille
    Paubelle, Etienne
    Jacquel, Arnaud
    Zylbersztejn, Florence
    Decroocq, Justine
    Poulain, Laury
    Sujobert, Pierre
    Jacque, Nathalie
    Adam, Kevin
    So, Jason C. C.
    Kosmider, Olivier
    Auberger, Patrick
    Hermine, Olivier
    Weinstock, David M.
    Lacombe, Catherine
    Mayeux, Patrick
    Vanasse, Gary J.
    Leung, Anskar Y.
    Moura, Ivan C.
    Bouscary, Didier
    Tamburini, Jerome
    SCIENCE ADVANCES, 2015, 1 (08):
  • [3] Inhibition of NOTCH4 sensitizes FLT3/ITD acute myeloid leukemia cells to FLT3 tyrosine kinase inhibition
    Zhu, Ruiqi
    Shirley, Courtney M.
    Chu, S. Haihua
    Li, Li
    Nguyen, Bao H.
    Seo, Jaesung
    Wu, Min
    Seale, Tessa
    Duffield, Amy S.
    Staudt, Louis M.
    Levis, Mark
    Hu, Yu
    Small, Donald
    LEUKEMIA, 2024, 38 (07) : 1581 - 1591
  • [4] Inhibition of NOTCH4 Sensitizes FLT3/ITD Acute Myeloid Leukemia Cells to FLT3 Tyrosine Kinase Inhibition
    Zhu, Ruiqi
    Shirley, Courtney
    Chu, Haihua
    Li, Li
    Bao Nguyen
    Seo, Jaesung
    Seale, Tessa
    Duffield, Amy
    Staudt, Louis M.
    Levis, Mark J.
    Hu, Yu
    Small, Donald
    BLOOD, 2023, 142
  • [5] Quizartinib for the treatment of FLT3/ITD acute myeloid leukemia
    Levis, Mark
    FUTURE ONCOLOGY, 2014, 10 (09) : 1571 - 1579
  • [6] The combination of FLT3 and DNA methyltransferase inhibition is synergistically cytotoxic to FLT3/ITD acute myeloid leukemia cells
    E Chang
    S Ganguly
    T Rajkhowa
    C D Gocke
    M Levis
    H Konig
    Leukemia, 2016, 30 : 1025 - 1032
  • [7] The combination of FLT3 and DNA methyltransferase inhibition is synergistically cytotoxic to FLT3/ITD acute myeloid leukemia cells
    Chang, E.
    Ganguly, S.
    Rajkhowa, T.
    Gocke, C. D.
    Levis, M.
    Konig, H.
    LEUKEMIA, 2016, 30 (05) : 1025 - 1032
  • [8] Glutaminolysis is a metabolic dependency in FLT3ITD acute myeloid leukemia unmasked by FLT3 tyrosine kinase inhibition
    Gallipoli, Paolo
    Giotopoulos, George
    Tzelepis, Konstantinos
    Costa, Ana S. H.
    Vohra, Shabana
    Medina-Perez, Paula
    Basheer, Faisal
    Marando, Ludovica
    Di Lisio, Lorena
    Dias, Joao M. L.
    Yun, Haiyang
    Sasca, Daniel
    Horton, Sarah J.
    Vassiliou, George
    Frezza, Christian
    Huntly, Brian J. P.
    BLOOD, 2018, 131 (15) : 1639 - 1653
  • [9] Shikonin exerts an anti-leukemia effect against FLT3-ITD mutated acute myeloid leukemia cells via targeting FLT3 tyrosine kinase and its downstream pathways
    Zhao, Mu-Nan
    Su, Long
    Song, Fei
    Wei, Zhi-Feng
    Qin, Tian-Xue
    Zhang, Yun-Wei
    Li, Wei
    Gao, Su-Jun
    ACTA HAEMATOLOGICA, 2023, : 310 - 323
  • [10] Maintenance therapy for FLT3-ITD-mutated acute myeloid leukemia
    Burchert, Andreas
    HAEMATOLOGICA, 2021, 106 (03) : 664 - 670
12345